MPAM
CRNX icon

Monarch Partners Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Monarch Partners Asset Management’s Portfolio CRNX Stock Details CRNX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$2.36M Sell
128,974
-1,886
-1% -$34.5K 0.7% 65
2022
Q3 		$2.57M Buy
+130,860
New +$2.57M 0.77% 58